Key facts
- This page summarizes Ram Waisbourd's Form 4 filing for 89bio, Inc. (ETNB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Feb 2022, 16:13.
Ram Waisbourd - 17 Feb 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)
- Reporting relationship
- Chief Operating Officer and Chief Business Officer
- Issuer ticker
- ETNB
- Reported as of
- 17 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2022, 16:13:20 UTC
- Prior SEC filing
- 03 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ram Waisbourd filed Form 4 for 89bio, Inc. (ETNB) on 22 Feb 2022.
Change
- Previous filing in this sequence was filed on 03 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ETNB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +6,250
- Change %
- Price
- $0.000000
- Shares after
- 6,250
- Date
- 17 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
ETNB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,500
- Change %
- +40%
- Price
- $0.000000
- Shares after
- 8,750
- Date
- 17 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ETNB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 17 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $4.44
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted stock units ("RSUs") that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
Represents RSUs that vest in equal installments on each of August 1, 2022, February 1, 2023 and August 1, 2023.
Footnote F3
This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.
SEC remarks
Chief Operating Officer and Chief Business Officer